Skip To Main Content
Barend M. Mol on Muck Rack

Barend M. Mol

As seen in: BMJ Open, medRxiv, European Journal of Vascular and Endovascular Surgery
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barend M.

Contact Barend M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High Levels of Plasma and Plaque IsoDGR-Modified Fibronectin are Associated with Rupture Prone Plaque Characteristics in Carotid Endarterectomy Patients

|
By Barend M. Mol, Tetiana Motsak, Joost K.R. Hoekstra, Valentina Osorio Zuluaga, Saskia Rumpff-Derksen, Ioanna Paspali-Strik, SoFong Cam Ngan, Gerard Pasterkamp, Siu Kwan Sze
| European Journal of Vascular and Endovascular Surgery Verified
aDepartment of Vascular Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands bDepartment Internal Medicine, Bogomolets National Medical University, Kyiv, Ukraine cDepartment of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, the Netherlands dPersuasiveDx BV (Ltd), Utrecht, the Netherlands eDepartment of Health Sciences, Brock University, St Catharines, Ontario, Canada fCentral Diagnostic Laboratory, UMC Utrecht, the Netherlands
Open in Who Shared Issue with article?

Medication adherence of patients with peripheral arterial disease to antithrombotic therapy: a systematic review

|
By Barend M. Mol, Çağdaş Ünlü, Noordwest Ziekenhuisgroep, Emilien CJ Wegerif
| BMJ Open Verified
Abstract Objectives Antithrombotic therapy (ATT) prevents atherothrombotic events (AE) in patients with peripheral arterial disease (PAD). However, the benefit may be compromised by poor medication adherence (MA). Therefore, our primary objective was the proportion of patients with PAD with poor MA in literature following patient-reported, pharmacy-reported or laboratory-reported outcome measurements.
Open in Who Shared Issue with article?

High levels of IsoDGR-modified fibronectin are associated with higher levels of macrophages and other rupture-prone plaque characteristics in patients undergoing carotid endarterectomy

|
By Tetiana Motsak, Barend M. Mol, Joost K.R. Hoekstra, Valentina Osorio Zuluaga
| medRxiv
The authors have declared no competing interest. No funding was retrieved for this study I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (31) Issue with article?
See all 4 articles